Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 5
2011 2
2012 4
2013 3
2015 2
2016 1
2017 9
2018 8
2019 8
2020 10
2021 9
2022 6
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer.
Lee KM, Lin CC, Servetto A, Bae J, Kandagatla V, Ye D, Kim G, Sudhan DR, Mendiratta S, González Ericsson PI, Balko JM, Lee J, Barnes S, Malladi VS, Tabrizi S, Reddy SM, Yum S, Chang CW, Hutchinson KE, Yost SE, Yuan Y, Chen ZJ, Fu YX, Hanker AB, Arteaga CL. Lee KM, et al. Cancer Immunol Res. 2022 Jul 1;10(7):829-843. doi: 10.1158/2326-6066.CIR-21-0826. Cancer Immunol Res. 2022. PMID: 35561311 Free PMC article.
Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer.
Kim MH, Kim GM, Ahn JM, Ryu WJ, Kim SG, Kim JH, Kim TY, Han HJ, Kim JY, Park HS, Park S, Park BW, Kim SI, Jeong J, Lee J, Paik S, Kim S, Jung KH, Cho EH, Sohn J. Kim MH, et al. Among authors: kim gm. J Natl Cancer Inst. 2023 Sep 7;115(9):1036-1049. doi: 10.1093/jnci/djad080. J Natl Cancer Inst. 2023. PMID: 37166557 Free PMC article.
Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA.
Bae M, Kim G, Lee TR, Ahn JM, Park H, Park SR, Song KB, Jun E, Oh D, Lee JW, Park YS, Song KW, Byeon JS, Kim BH, Sohn JH, Kim MH, Kim GM, Chie EK, Kang HC, Kong SY, Woo SM, Lee JE, Ryu JM, Lee J, Kim D, Ki CS, Cho EH, Choi JK. Bae M, et al. Among authors: kim gm. Nat Commun. 2023 Apr 10;14(1):2017. doi: 10.1038/s41467-023-37768-3. Nat Commun. 2023. PMID: 37037826 Free PMC article.
On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates.
Kim CG, Kim MH, Kim JH, Kim SG, Kim GM, Kim TY, Ryu WJ, Kim JY, Park HS, Park S, Cho YU, Park BW, Kim SI, Jeong J, Sohn J. Kim CG, et al. Among authors: kim gm. Breast Cancer Res. 2023 Jan 12;25(1):4. doi: 10.1186/s13058-022-01601-4. Breast Cancer Res. 2023. PMID: 36635767 Free PMC article.
Genomic landscape of extraordinary responses in metastatic breast cancer.
Lim SM, Kim E, Jung KH, Kim S, Koo JS, Kim SI, Park S, Park HS, Park BW, Cho YU, Kim JY, Paik S, Kwon NJ, Kim GM, Kim JH, Kim MH, Jeon MK, Kim S, Sohn J. Lim SM, et al. Among authors: kim gm. Commun Biol. 2021 Apr 9;4(1):449. doi: 10.1038/s42003-021-01973-x. Commun Biol. 2021. PMID: 33837242 Free PMC article.
Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies.
Moon YW, Kim SK, Lee KS, Lee MH, Park YH, Park KH, Kim GM, Lim S, Lee SA, Choi JD, Baek E, Han H, Baek S, Im SA. Moon YW, et al. Among authors: kim gm. Cancer Res Treat. 2023 Jul;55(3):766-777. doi: 10.4143/crt.2022.987. Epub 2023 Jan 19. Cancer Res Treat. 2023. PMID: 36701846 Free PMC article. Clinical Trial.
First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors.
Janku F, Beom SH, Moon YW, Kim TW, Shin YG, Yim DS, Kim GM, Kim HS, Kim SY, Cheong JH, Lee YW, Geiger B, Yoo S, Thurston A, Welsch D, Rudoltz MS, Rha SY. Janku F, et al. Among authors: kim gm. Invest New Drugs. 2022 Oct;40(5):1001-1010. doi: 10.1007/s10637-022-01277-9. Epub 2022 Jul 8. Invest New Drugs. 2022. PMID: 35802288 Free PMC article. Clinical Trial.
67 results